Analyst on Upcoming Election: ‘This is absolutely … the most important election ever for the modern day healthcare investor.’
Baird, an employee-owned international capital markets, private equity, wealth and asset management firm, will host its annual Health Care Conference in New York City on Sept. 5-6. The conference will bring together institutional and private equity investor attendees to hear presentations from company executives representing more than 80 public and privately held companies across a range of sectors including Biotechnology, Distribution & Services, Life Sciences & Diagnostics, Medical Technology, Facilities, Specialty Pharmaceuticals, and Cardiovascular Devices.
As a preview to the conference, Baird Senior Research Analyst Whit Mayo who covers Health Care Facilities & Services shares his thoughts on the opportunities and challenges facing public and private companies in the sector in a pivotal election year.
Q&A with Senior Research Analyst Whit Mayo
On the heels of Q2 earnings, how has the health care sector performed so far this year and what is the outlook for the remainder of 2012?
Overall, sector performance is very mixed, but the group as a whole has held in okay this year. For our part, we focus on a very narrow sliver of the health care world, mostly facility-based providers, and we’d characterize the outlook for the remainder of 2012 as complicated. We’ve actually seen most companies exceed consensus estimates and the forward outlooks have been ratcheted modestly higher. However, exiting 2Q earnings, investors have generally used the positive news to sell these stocks and position themselves for the election and deficit conversation.
What impact will the upcoming presidential election have on the health care sector?
This is absolutely, in the market’s view, the most important election ever for the modern day health care investor. There are so many permutations of possible outcomes that one can analyze. If President Barack Obama wins his bid for reelection, the market will be forced to assign a material probability of increased coverage via the Patient Protection and Affordable Care Act (PPACA). If Republican Presidential candidate Mitt Romney wins, the market will be forced to assign a material probability that the GOP will attempt to dismantle reform, potentially leave $700 billion of provider cuts in place and then go so far as to assign a risk that Republican Vice Presidential candidate Paul Ryan’s philosophical view on premium support/defined contribution-like health care could actually be presented as policy. I personally think a Romney/Ryan victory would be bad for the entire health care sector. Investors will have uncertainty on uncertainty.
How is the recent Supreme Court ruling on health care impacting health care stocks, both positively and negatively?
Reform, as written by policymakers and interpreted by the Congressional Budget Office, should be positive for almost every group in healthcare. More coverage means positive implications for pharma, hospitals, medical device manufactures, managed care, distributors, etc. Everyone had a price to pay, but as the law is written, just about everyone comes out okay – some less than others. Managed care would have liked a better deal. Some of the post-acute care providers, notably home health, will see nothing but negatives from the deal. Home health gave up $55 billion in future reimbursement and will not benefit by a penny from increased coverage. With that said, all the recent attention paid to the Supreme Court ruling has been negative for the sector, as multiples have come down. Investors just want clarity.
How are companies preparing for or dealing with the uncertainty over possible Federal budget cuts that may be triggered early next year?
Elections and deficits almost always drive Medicare policy. Providers are used to these challenges and understand that they are inherently a “price taker” and constantly at risk. The actual rate cuts that providers will see, in all likelihood will prove to be very manageable. Unfortunately, the lack of visibility and clarity on the broader policy issues inhibits their ability to execute on a strategic plan. Few will take on elevated risk in an unknown environment, unless the reward greatly outweighs the risk.
For additional perspective from Mayo, please read his weekly Health Care Facilities and Services research note.
About Whit Mayo
Whit Mayo is Baird’s Senior Analyst covering Health Care Facilities & Services. Prior to joining Baird in 2008, he was a senior analyst at Stephens Inc. covering Healthcare Facilities & Services, specifically acute care hospitals, behavioral hospitals, alternate site and post-acute providers as well as Healthcare IT. Prior to joining Stephens Inc., Whit was an investment analyst at Reliance Trust. In 2008, he was recognized in The Wall Street Journal’s “Best on the Street” annual survey in the Health-Care Providers sector. He received a BA in Economics from The University of the South (Sewanee), in Sewanee, Tenn.
About Baird Research
Baird’s Research Department consists of approximately 110 research professionals covering more than 660 U.S. companies. Baird analysts have been recognized repeatedly in The Wall Street Journal’s annual “Best on the Street” survey and honored by StarMine as top analysts.
An investment should not be made on this content, as this is not a complete analysis of every material fact regarding any company, industry or security. Please click here for a complete list of the companies Baird covers.
Baird is an employee-owned, international wealth management, capital markets, private equity and asset management firm with offices in the United States, Europe and Asia. Established in 1919, Baird has more than 2,700 associates serving the needs of individual, corporate, institutional and municipal clients. Baird has nearly $94 billion in client assets. Committed to being a great place to work, Baird ranked No. 21 on FORTUNE’s 100 Best Companies to Work For in 2012 – its ninth consecutive year on the list. Baird’s principal operating subsidiaries are Robert W. Baird & Co. in the United States and Robert W. Baird Group Ltd. in Europe. Baird also has an operating subsidiary in Asia supporting Baird’s private equity operations. For more information, please visit Baird’s Web site at rwbaird.com.
Baird Public Relations